Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-19-054144
Filing Date
2019-10-25
Accepted
2019-10-25 17:01:31
Documents
2
Period of Report
2019-10-25

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 2150
2 POA DOCUMENT poa.txt EX-24.3_877028 4417
  Complete submission text file 0001209191-19-054144.txt   7966
Mailing Address C/O AMAG PHARMACEUTICALS, INC. 1100 WINTER STREET WALTHAM MA 02451
Business Address
SCOON DAVEY (Reporting) CIK: 0001270110 (see all company filings)

Type: 3 | Act: 34 | File No.: 811-23446 | Film No.: 191170563

Mailing Address 1633 BROADWAY NEW YORK NY 10019
Business Address 1633 BROADWAY NEW YORK NY 10019 617-951-7831
AllianzGI Artificial Intelligence & Technology Opportunities Fund (Issuer) CIK: 0001778114 (see all company filings)

EIN.: 000000000 | State of Incorp.: MA